Showing results (2361-2370 of 3,507) with videos related to
Sort By:
Pageof 351
Eclinicalmedicine|December 25, 2024
AI education for cliniciansTim Schubert, Tim Oosterlinck, Robert D Stevens, et al.Eclinicalmedicine|December 25, 2024
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome setRobert Samuel, Stephen R Knight, Richard Adams, et al.Eclinicalmedicine|January 7, 2025
Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling studyZhuoru Zou, Christopher K Fairley, Jason J Ong, et al.Eclinicalmedicine|January 15, 2025
Cost-effectiveness of targeted next-generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysisSuvesh Shrestha, Angelina Addae, Cecily Miller, et al.Eclinicalmedicine|January 13, 2025
Associations of dietary choline intake and kidney function with hyperuricemia in Chinese children and adolescents: a cross-sectional studyChengping Li, Jing Li, Zhiquan Diao, et al.Eclinicalmedicine|January 13, 2025
Prevalence of post-acute sequelae of SARS-CoV-2 infection in people living with HIV: a systematic review with meta-analysisDimitra V Pouliopoulou, Nicole Billias, Joy C MacDermid, et al.Eclinicalmedicine|January 13, 2025
Global assessment of leukemia care quality: insights from the quality of care index (QCI) from 1990 to 2021Yuzhe Pan, Qian Liu, Nan Zhang, et al.Eclinicalmedicine|January 10, 2025
Faecal microbiota transplantation for patients with diabetes type 1 and severe gastrointestinal neuropathy (FADIGAS): a randomised, double-blinded, placebo-controlled trialKatrine Lundby Høyer, Simon Mark Dahl Baunwall, Ditte Smed Kornum, et al.Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.Eclinicalmedicine|February 3, 2025
Post infectious fatigue and circadian rhythm disruption in long-COVID and other infections: a need for further researchAchilleas Livieratos, Steven W Lockley, Sotirios TsiodrasPageof 351